MedPath
HSA Product

DATROWAY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL

Product approved by Health Sciences Authority (SG)

Basic Information

DATROWAY POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Regulatory Information

SIN17234P

May 10, 2025

Prescription Only

Therapeutic

INTRAVENOUS

May 23, 2025

May 30, 2025

Company Information

ASTRAZENECA SINGAPORE PTE LTD

Active Ingredients

datopotamab deruxtecan

Strength: 100 mg/vial

© Copyright 2025. All Rights Reserved by MedPath